These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 11265283)

  • 1. Crystallization and crystal structure determination of ribonuclease A-ribonuclease inhibitor protein complex.
    Kobe B
    Methods Mol Biol; 2001; 160():201-11. PubMed ID: 11265283
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanism of ribonuclease inhibition by ribonuclease inhibitor protein based on the crystal structure of its complex with ribonuclease A.
    Kobe B; Deisenhofer J
    J Mol Biol; 1996 Dec; 264(5):1028-43. PubMed ID: 9000628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toward rational design of ribonuclease inhibitors: high-resolution crystal structure of a ribonuclease A complex with a potent 3',5'-pyrophosphate-linked dinucleotide inhibitor.
    Leonidas DD; Shapiro R; Irons LI; Russo N; Acharya KR
    Biochemistry; 1999 Aug; 38(32):10287-97. PubMed ID: 10441122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A structural basis of the interactions between leucine-rich repeats and protein ligands.
    Kobe B; Deisenhofer J
    Nature; 1995 Mar; 374(6518):183-6. PubMed ID: 7877692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complex between bovine ribonuclease A and porcine ribonuclease inhibitor crystallizes in a similar unit cell as free ribonuclease inhibitor.
    Kobe B; Ma Z; Deisenhofer J
    J Mol Biol; 1994 Aug; 241(2):288-91. PubMed ID: 8057371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deamidation in proteins: the crystal structure of bovine pancreatic ribonuclease with an isoaspartyl residue at position 67.
    Capasso S; Di Donato A; Esposito L; Sica F; Sorrentino G; Vitagliano L; Zagari A; Mazzarella L
    J Mol Biol; 1996 Apr; 257(3):492-6. PubMed ID: 8648618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-level soluble production and characterization of porcine ribonuclease inhibitor.
    Klink TA; Vicentini AM; Hofsteenge J; Raines RT
    Protein Expr Purif; 2001 Jul; 22(2):174-9. PubMed ID: 11437592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fragment-based lead discovery using X-ray crystallography.
    Hartshorn MJ; Murray CW; Cleasby A; Frederickson M; Tickle IJ; Jhoti H
    J Med Chem; 2005 Jan; 48(2):403-13. PubMed ID: 15658854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel strategy for the crystallization of proteins: X-ray diffraction validation.
    Larson SB; Day JS; Cudney R; McPherson A
    Acta Crystallogr D Biol Crystallogr; 2007 Mar; 63(Pt 3):310-8. PubMed ID: 17327668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular recognition of human eosinophil-derived neurotoxin (RNase 2) by placental ribonuclease inhibitor.
    Iyer S; Holloway DE; Kumar K; Shapiro R; Acharya KR
    J Mol Biol; 2005 Apr; 347(3):637-55. PubMed ID: 15755456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorescence assay for the binding of ribonuclease A to the ribonuclease inhibitor protein.
    Abel RL; Haigis MC; Park C; Raines RT
    Anal Biochem; 2002 Jul; 306(1):100-7. PubMed ID: 12069420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular similarity analysis uncovers heterogeneous structure-activity relationships and variable activity landscapes.
    Peltason L; Bajorath J
    Chem Biol; 2007 May; 14(5):489-97. PubMed ID: 17524980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Ribonuclease A by polyphenols present in green tea.
    Ghosh KS; Maiti TK; Debnath J; Dasgupta S
    Proteins; 2007 Nov; 69(3):566-80. PubMed ID: 17623866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing the potency of a cytotoxin with an arginine graft.
    Fuchs SM; Rutkoski TJ; Kung VM; Groeschl RT; Raines RT
    Protein Eng Des Sel; 2007 Oct; 20(10):505-9. PubMed ID: 17954521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of calf spleen purine nucleoside phosphorylase with two full trimers in the asymmetric unit: important implications for the mechanism of catalysis.
    Bzowska A; Koellner G; Wielgus-Kutrowska B; Stroh A; Raszewski G; Holý A; Steiner T; Frank J
    J Mol Biol; 2004 Sep; 342(3):1015-32. PubMed ID: 15342253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystallization and preliminary X-ray analysis of two inhibitor complexes of the catalytic domain of death-associated protein kinase.
    Yamakawa A; Ogata H; Morita K; Shibata N; Andou N; Sanuki H; Yamada K; Hioki T; Ishii T; Higuchi Y
    Acta Crystallogr D Biol Crystallogr; 2004 Apr; 60(Pt 4):764-6. PubMed ID: 15039579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The solution structure and dynamics of human pancreatic ribonuclease determined by NMR spectroscopy provide insight into its remarkable biological activities and inhibition.
    Kövér KE; Bruix M; Santoro J; Batta G; Laurents DV; Rico M
    J Mol Biol; 2008 Jun; 379(5):953-65. PubMed ID: 18495155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dynamic structure of ribonuclease A in crystal and in solution. Two major types of intramolecular motions].
    Abaturov LV; Lebedev IuO; Nosova NG; Shliapnikov SV
    Mol Biol (Mosk); 1999; 33(4):630-40. PubMed ID: 10546216
    [No Abstract]   [Full Text] [Related]  

  • 19. Automated technologies and novel techniques to accelerate protein crystallography for structural genomics.
    Manjasetty BA; Turnbull AP; Panjikar S; Büssow K; Chance MR
    Proteomics; 2008 Feb; 8(4):612-25. PubMed ID: 18210369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytoplasmic ribonuclease inhibitor.
    Shapiro R
    Methods Enzymol; 2001; 341():611-28. PubMed ID: 11582809
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.